Res Nova Biologics Recruits Abortion Pill Reversal Founder to Scientific Advisory Board
View the full release here: https://www.businesswire.com/news/home/20231017959162/en/
- View the full release here: https://www.businesswire.com/news/home/20231017959162/en/
Dr. Delgado is an expert in the biology of pregnancy and the abortion pill, being the founder of “Abortion Pill Reversal” and having been the first to publish in the peer-reviewed literature successful reversal of mifepristone administration using progesterone treatment1. - Res Nova is developing FloraStilbene™, a proprietary formulation of RU-486 and pterostilbene which has been shown to overcome tumor associated immune suppression2 and increases responsiveness to chemotherapy and immunotherapy3.
- “The similarities between pregnancy and oncology, including angiogenesis, immune modulation, and rapid growth are striking,” said Dr. George Delgado.
- “In my opinion the concept of leveraging the effects of the abortion pill in life-saving as opposed to a life-taking scenario is extremely exciting.